Rebuttal to Deacon and Holst: “Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1” versus “Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective”

By Demuth H-U.   Hinke S.A.   Pederson R.A.   McIntosh C.H.S.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 2, 2002-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Role of Hepatocyte Nuclear Factor 1α and 1β in the Transcriptional Regulation of Human Dipeptidyl Peptidase IV during Differentiation of Caco-2 Cells

By Erickson R.H.   Lai R.S.   Kim Y.S.  

Biochemical and Biophysical Research Communications, Vol. 270, Iss. 1, 2000-04 ,pp. : 235-239

Elsevier

Access to resources Recommend Favorite

Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer

By Busek P.   Malik R.   Sedo A.  

The International Journal of Biochemistry and Cell Biology, Vol. 36, Iss. 3, 2004-03 ,pp. : 408-421

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

By Kuhlmann Olaf   Paehler Axel   Weick Idelette   Funk Christoph   Pantze Michael   Zell Manfred   Timm Uwe  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 840-852

Informa Healthcare

Access to resources Recommend Favorite

Dipeptidyl Peptidase IV (DP IV/CD26) mRNA Expression in PWM-Stimulated T-Cells Is Suppressed by Specific DP IV Inhibition, an Effect Mediated by TGF-β₁

By Arndt M.   Lendeckel U.   Spiess A.   Faust J.   Neubert K.   Reinhold D.   Ansorge S.  

Biochemical and Biophysical Research Communications, Vol. 274, Iss. 2, 2000-08 ,pp. : 410-414

Elsevier

Access to resources Recommend Favorite